Moreover, treatment with a specific caspase-9 inhibitor significantly rescued both PCD and microphthalmia in morphant embryos whereas a caspase-1 inhibitor had no effect (Fig 4G, L and M), indicating a specific role of caspase-9 in the pathogenesis of microphthalmia in our model. The gene discussed is CASP1; the disease is microphthalmia.